Strategy Stock (MSTR)

Upside – $LPCN +40% (Health Canada approves TLANDO for testosterone replacement therapy) – $APUS +9.4% (extends a high-volume rally tied to the BlockAssure agreement to build and operate the AssureChain insurance network) – $PENG +4.3% (Q4 beat and FY27 sales and EPS outlook topped prior guidance and Street expectations on accelerating AI-infrastructure demand) – CNQ …

Upside – AMOD +108.5% (closed a bitcoin-funded private placement and regained Nasdaq listing compliance) – NIVF +40.0% (closed an approximately $1.25M public offering) – SDEV +36.0% (extends Thursday’s surge in the SKY-token treasury name; no clear fresh company-specific catalyst identified) – TNMG +20.0% (agreed to sell its Japanese business in a $5.5M management buyout) – …

Upside – $MEDS +30% (litigation settlement is expected to extinguish about $19 million of liabilities and retire 364,099 shares) – $USDE +17%, $PURR +7.0%, $MSTR +2.8%, $HOOD +2.2% (crypto and tokenization-linked stocks rise as Bitcoin rallies and regulators grant temporary relief for tokenized U.S. stock trading) – $STUB +6.0% (Citi upgrades to Buy from Neutral) …

Surprise #4: Market structure, so positive an influence in 2023-25 begins to weigh on equities after a clear change in market momentum leads to a deleveraging in the leveraged, passive and quantitative equity fund worlds With so many positioned on the same side of the (bullish) boat, retail investors begin to liquidate from equity funds – …

Riddle me this, Bitcoiners: To give you a sense of how bad an asset allocator Strategy’s ($MSTR) Michael Saylor is… he started buying Bitcoin at $11,000. The current price is $60,000 but he has an unrealized loss of over $15 billion. Position: None